AWM
BIIB icon

AE Wealth Management’s Biogen BIIB Stock Holding History

AE Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$306K Sell
1,667
-47
-3% -$8.66K ﹤0.01% 1368
2025
Q4 		$302K Buy
1,714
+252
+17% +$41.2K ﹤0.01% 1308
2025
Q3 		$205K Buy
+1,462
New +$198K ﹤0.01% 1392
2025
Q2 		– Sell
-1,731
Closed -$237K – 2172
2025
Q1 		$237K Buy
1,731
+141
+9% +$20.2K ﹤0.01% 1205
2024
Q4 		$243K Buy
+1,590
New +$268K ﹤0.01% 1188
2024
Q3 		– Sell
-1,118
Closed -$259K – 1241
2024
Q2 		$259K Buy
+1,118
New +$243K ﹤0.01% 1078
2024
Q1 		– Sell
-2,014
Closed -$493K – 1222
2023
Q4 		$493K Buy
2,014
+348
+21% +$85.5K ﹤0.01% 1446
2023
Q3 		$428K Buy
1,666
+398
+31% +$106K ﹤0.01% 1461
2023
Q2 		$361K Sell
1,268
-79
-6% -$23.5K ﹤0.01% 1533
2023
Q1 		$374K Buy
1,347
+493
+58% +$136K ﹤0.01% 1462
2022
Q4 		$236K Sell
854
-20,042
-96% -$5.66M ﹤0.01% 1605
2022
Q3 		$5.58M Buy
+20,896
New +$4.44M 0.04% 410
2021
Q4 		– Sell
-1,085
Closed -$307K – 1696
2021
Q3 		$307K Buy
1,085
+277
+34% +$90.8K ﹤0.01% 1357
2021
Q2 		$280K Sell
808
-12,707
-94% -$3.85M ﹤0.01% 1365
2021
Q1 		$3.78M Buy
13,515
+5,953
+79% +$1.61M 0.04% 379
2020
Q4 		$1.85M Sell
7,562
-6,352
-46% -$1.64M 0.02% 516
2020
Q3 		$3.95M Buy
13,914
+7,477
+116% +$2.09M 0.06% 274
2020
Q2 		$1.72M Buy
6,437
+4,524
+236% +$1.36M 0.03% 451
2020
Q1 		$605K Sell
1,913
-41
-2% -$12.4K 0.01% 623
2019
Q4 		$580K Buy
1,954
+380
+24% +$105K 0.01% 691
2019
Q3 		$366K Sell
1,574
-2,111
-57% -$492K 0.01% 711
2019
Q2 		$862K Buy
3,685
+2,683
+268% +$620K 0.03% 447
2019
Q1 		$237K Buy
+1,002
New +$316K 0.02% 548

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AE Wealth Management's BIIB Position: Q1 2026 in Review

AE Wealth Management reduced its Biogen (BIIB) stake by 2.7% in Q1 2026, selling an estimated $8.66K and leaving 1,667 shares worth $306K. The position accounts for ﹤0.01% of the portfolio, ranked #1368.

AE Wealth Management first reported a position in BIIB in Q1 2019 and has held it in 23 quarters since. The position peaked at $5.58M in Q3 2022. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • AE Wealth Management held 1,667 shares of Biogen worth $306K as of Q1 2026.
  • AE Wealth Management sold 47 Biogen shares in Q1 2026, an estimated $8.66K.
  • Biogen made up ﹤0.01% of AE Wealth Management's portfolio in Q1 2026, its #1368 holding.
  • AE Wealth Management first reported a position in Biogen in Q1 2019 and has held it in 23 quarters since.
  • AE Wealth Management's Biogen position peaked at $5.58M in Q3 2022.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on AE Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.